Literature DB >> 17126101

Surgical experience for the pulmonary artery sarcoma.

Ayako Maruo1, Yutaka Okita, Kenji Okada, Teruo Yamashita, Satoshi Tobe, Nobuhiro Tanimura.   

Abstract

BACKGROUND: Pulmonary sarcoma arising from the pulmonary artery is a rare disease and its prognosis is disastrous.
METHODS: Five patients who underwent surgery for pulmonary artery sarcoma were reviewed.
RESULTS: All patients except one were initially diagnosed with pulmonary embolism. One patient with preoperative profound shock could not wean from cardiopulmonary bypass. Two patients are still surviving for 36 and 30 months, respectively.
CONCLUSIONS: Early diagnosis and complete surgical resection is perhaps the best way to improve patients with pulmonary artery sarcoma.

Entities:  

Mesh:

Year:  2006        PMID: 17126101     DOI: 10.1016/j.athoracsur.2006.07.018

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Primary pulmonary artery sarcoma: a close associate of pulmonary embolism-20-year observational analysis.

Authors:  Debabrata Bandyopadhyay; Tanmay S Panchabhai; Navkaranbir S Bajaj; Pradnya D Patil; Matthew C Bunte
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

2.  Pulmonary artery sarcoma: a rare disease.

Authors:  Liana Sousa Coelho; Suzana Erico Tanni; Sérgio Marrone Ribeiro; Daniele Cristina Catâneo; Jacob Antônio Della Coletta; Irma de Godoy
Journal:  BMJ Case Rep       Date:  2010-01-13

Review 3.  Surgery for malignant lesions of the chest which extensively involved the mediastinum, lung, and heart.

Authors:  Yugo Tanaka; Daisuke Hokka; Hiroyuki Ogawa; Nahoko Shimizu; Takeshi Inoue; Hiroshi Tanaka; Yutaka Okita; Yoshimasa Maniwa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-05-24

4.  Clinical Characteristics and Treatment Outcomes of Primary Pulmonary Artery Sarcoma in Korea.

Authors:  Yunkyoung Lee; Hyun Jung Kim; Heeyoung Yoon; Chang Min Choi; Yeon Mok Oh; Sang Do Lee; Chae Man Lim; Woo Sung Kim; Younsuck Koh; Jae Seung Lee
Journal:  J Korean Med Sci       Date:  2016-11       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.